The True Story Behi...
Health Care: Drugs
Akorn Inc. (AKRX: NASDAQ)
$14.55 -0.28 | -1.89%
05/22/13 - 04:00 PM ET
377.34K / 634.80K
Vol / Avg. Vol:14.83 / 14.83
Open / Prev. Close:14.47 - 14.99
Today's Range:11.73 - 16.87
52 Wk Range:11.00%
Performance YTD:TheStreet Rating:
Portfolios with AKRX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 18
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 16
- UserGFNN Stockdiagnostics 11
- Userpharmacy
- UserGFNN Stockdiagnostics 4
- UserGFNN Stockdiagnostics
- ContributorStocks At New 52-Week Highs...
Latest AKRX Headlines from TheStreet
- AKRX Crosses Below Key Moving Average Level 05.07.13 | 11:05 am
- 5 Stock Insiders are Gobbling Up 12.19.12 | 12:12 pm
- Akorn CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 12:08 pm
- Cramer's 'Mad Money" Recap: Curb Your Enthusiasm 07.11.12 | 07:07 pm
- 7 High-Volume Stocks With Relative Strength 07.09.12 | 02:07 pm
- Akorn Stock Hits New 52-Week High (AKRX) 06.19.12 | 11:06 am
- Akorn Reaches New 52-Week High (AKRX) 06.08.12 | 03:06 pm
- Akorn Inc. (AKRX): Today's Featured Drugs Loser 06.06.12 | 06:06 pm
- Akorn Inc. (AKRX): Today's Featured Drugs Loser 06.06.12 | 05:06 pm
- Akorn Stock Hits New 52-Week High (AKRX) 05.30.12 | 02:05 pm
Press Releases for AKRX
- Akorn Reports 2012 Fourth Quarter And Year-End Financial Results - Business Wire 02.26.13 | 07:02 am
- Akorn Provides Financial Guidance For 2013 - Business Wire 01.17.13 | 02:01 pm
- Akorn Reports Third Quarter 2012 Financial Results - Business Wire 11.06.12 | 06:11 am
- Akorn Announces The Approval And Launch Of Generic Prometrium® - Business Wire 10.24.12 | 06:10 am
- Akorn’s Chairman Adopts 10b5-1 Trading Plan - Business Wire 09.24.12 | 11:09 am
- Akorn Announces New Management Appointments - Business Wire 08.07.12 | 07:08 am
- Akorn Reports Preliminary Second Quarter 2012 Financial Results - Business Wire 08.07.12 | 07:08 am
- Akorn To File Amended Unaudited Financial Statements For The Quarter Ended March 31, 2012 - Business Wire 08.07.12 | 06:08 am
- Akorn Reports Record First Quarter 2012 Financial Results - Business Wire 05.08.12 | 06:05 am
- Akorn Announces The Approval And Launch Of Generic Vancocin® - Business Wire 04.10.12 | 06:04 am
Partner Headlines for AKRX
- Akorn Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 05.07.13 | 10:05 am
- Akorn Earnings: Your Sneak Peek to the Big Announcement - Wall St. Cheat Sheet 05.06.13 | 06:05 am
- 5 Big Buys By Oak Ridge Investments - Seeking Alpha 11.10.12 | 01:11 am
- Weekly CFO Sells Highlight: ASGN, COF, AKRX, MCRS, GILD, ROP, PLL - NASDAQ 09.24.12 | 02:09 pm
- Healthcare Business Review: Savient's Favorable RULING, Forest Gets FDA OKAY - Wall St. Cheat Sheet 07.24.12 | 08:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 07.09.12 | 09:07 am
- Las Vegas Sands a BUY and 4 Must-See Expert Insights - Wall St. Cheat Sheet 07.09.12 | 04:07 am
- Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Press Releases - Zacks 02.08.12 | 09:02 am
- Akorn, Inc. - Momentum - Zacks 02.08.12 | 01:02 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.20.12 | 09:01 am
